S Broder

The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

Jan Balzarini, Gil-Jong Kang, Maha Dalal et al. · Molecular Pharmacology · 1987 · 234 citations

The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.

James A. Kelley, Charles L. Litterst, Jasmine Roth et al. · Drug Metabolism and Disposition · 1987 · 78 citations

Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.

Neil R. Hartman, Gurpreet S. Ahluwalia, David A. Cooney et al. · Molecular Pharmacology · 1991 · 51 citations

2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.

R Masood, Gurpreet S. Ahluwalia, David A. Cooney et al. · Molecular Pharmacology · 1990 · 45 citations

Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.

Gurpreet S. Ahluwalia, David A. Cooney, Neil R. Hartman et al. · Drug Metabolism and Disposition · 1993 · 42 citations